| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:1039.)
© 2008 American Heart Association, Inc.
Research Letters |
From the Emory University (F.N., G.C., M.L., M.C.), Atlanta, Ga; Brown University (E.F.), Providence, RI; Wayne State University (S.C.), Detroit, Mich; University of California, San Francisco (J.C.H.); University of South Alabama (R.Z.), Mobile; University of Virginia, Charlottesville (K.J.); San Francisco General Hospital (D.B.), Calif; University of Pennsylvania (S.K.), Philadelphia.
Correspondence to Fadi Nahab, MD, 1001 Garden View Drive NE #711, Atlanta, GA 30319. E-mail fnahab{at}emory.edu
Abstract
Background and Purpose— There are limited data on the prevalence and prognosis of asymptomatic intracranial stenosis (AIS).
Methods— Baseline cerebral angiograms and MR angiograms were used to determine AIS (50% to 99%) coexistent to symptomatic intracranial stenosis for patients enrolled in the Warfarin-Aspirin Symptomatic Intracranial Disease study.
Results— Coexisting AIS were detected in 18.9% (n=14/74) of patients undergoing 4-vessel cerebral angiography and 27.3% (n=65/238) of patients undergoing MR angiogram. During a mean follow-up period of 1.8 years, no ischemic strokes were attributable to an AIS on cerebral angiography and 5 ischemic strokes (5.9%, 95% CI: 2.1% to 12.3%) occurred in the AIS territory on MR angiogram (risk at 1 year=3.5%, 95% CI: 0.8% to 9.0%).
Conclusions— Whereas the prevalence of coexisting AIS (50% to 99%) in patients with symptomatic stenosis is high, the risk of stroke from these asymptomatic stenoses is low.
Key Words: atherosclerosis diabetes intracranial disease intracranial stenosis prognosis risk factors stroke
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |